Show simple item record

dc.contributor.authorKarimi-Sales, E
dc.contributor.authorMohaddes, G
dc.contributor.authorAlipour, MR
dc.date.accessioned2018-08-26T04:55:21Z
dc.date.available2018-08-26T04:55:21Z
dc.date.issued2018
dc.identifier.urihttp://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/38328
dc.description.abstractChalcones form an important group of natural compounds and flavonoid precursors which are abundant in fruits, vegetables, and edible plants. These compounds have many beneficial properties including anti-inflammatory, anti-microbial, antioxidant, anti-cancer, anti-amyloid, anti-diabetic, anti-obesity, hypolipidemic, and cytoprotective. Chalcone derivatives have protective effects on the liver in nonalcoholic fatty liver disease, alcoholic fatty liver, drug- and toxicant-induced liver injury, and liver cancer through several mechanisms. Chalcones improve adipocytes function and adiponectin secretion. They inhibit triglyceride synthesis, activating factors of hepatic stellate cells and extracellular matrix deposition and also elevate fatty acid oxidation. These effects of chalcones lead to liver injury improvement. In conclusion, chalcones with antioxidant, anti-fibrotic, and anti-inflammatory properties decrease liver injury markers and histological abnormality in liver injury.
dc.language.isoEnglish
dc.relation.ispartofPharmacological research
dc.titleChalcones as putative hepatoprotective agents: Preclinical evidence and molecular mechanisms.
dc.typearticle
dc.citation.volume129
dc.citation.spage177
dc.citation.epage187
dc.citation.indexPubmed
dc.identifier.DOIhttps://doi.org/10.1016/j.phrs.2017.11.022


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record